News

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced its participation and presence at the Heart Rhythm 2021 conference, taking place in person at the Boston...

Taking reprocessing to the next level requires investment in new technologies, clinical integration.

BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would...

First of its Kind FDA Action Allows In-Office and At-Home Measurement for Potentially Life-Threatening Side Effect of Certain Medications.

The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence.

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the...

Following reports that the Joint Commission is cracking down on insufficient protocols related to in-house reprocessing of reusable cables, Innovative Health seeks to raise awareness of dangers of noncompliance and educate industry on proper...

Constructive Feedback Helps Cardiology Practices Understand How to Improve their Remote Monitoring Programs

  FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures Reduced need for general anesthesia accelerates...

The Company recently increased its procedural volume targets due to accelerated technology usage; BioSig expands its commercial team to target technology adoption across three strategic regions